Celltrion | 068270 - Ebitda

Stock Price
206,000.00
Daily Change
6,000.00 3.00%
Monthly
-15.75%
Yearly
9.93%
Q1 Forecast
195,060.60

Celltrion reported KRW374.56B in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -9.69M 12.21M Dec/2025
Celltrion KRW 374.56B 352.67B Sep/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Moderna USD -790M 582M Dec/2025
Organon & Co USD 383M 135M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Tectonic Therapeutic USD -13.48M 5.73M Dec/2024
Viatris USD 1B 151.5M Dec/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025